PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against PepGen Inc. and certain officers for alleged violations of federal securities laws during the Class Period from March 7, 2024, to March 3, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased PepGen securities during the specified Class Period [2]. - The complaint alleges that Defendants made materially false and misleading statements regarding the effectiveness and safety of PGN-EDO51, the CONNECT2 study's suitability for FDA approval, and the overall clinical and commercial prospects of PepGen [3]. Group 2: Next Steps for Investors - Investors who suffered losses in PepGen have until August 8, 2025, to request appointment as lead plaintiff in the class action [4]. - A copy of the Complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful in the case [5]. - Bronstein, Gewirtz & Grossman, LLC is recognized for representing investors in securities fraud class actions and has recovered significant amounts for investors nationwide [6].